Tessellate Therapeutics Inc

Biotechnology company · Henderson, Nevada, United States

Tessellate Therapeutics Inc is a biotechnology company headquartered in Henderson, Nevada, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $80,000 sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Tessellate Therapeutics at a glance

Typebiotechnology company

HeadquartersHenderson, Nevada, United States

Earliest incorporation on record2021

SEC CIK1891542

What does Tessellate Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $80,000 sold (2021).

Frequently asked questions about Tessellate Therapeutics

Where is Tessellate Therapeutics headquartered?

Tessellate Therapeutics Inc is headquartered in Henderson, Nevada, United States.

What does Tessellate Therapeutics do?

Tessellate Therapeutics Inc is a biotechnology company.

When was Tessellate Therapeutics founded?

The earliest incorporation on record for Tessellate Therapeutics Inc is in 2021, according to public company registers.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences